Abstract
References
- Bhowmik D, Rajalakshmi S, Sampath Kumar KP (2014). Tablet manufacturing process and defects of tablets. Elixir Pharmacy 70: 24368-74.
- Comoglu T, Gonul N (2005). Quality control studies on conventional Carbamazepine tablets available on the Turkish drug market. Turk J Med Sci 35(4): 217-221.
- Gundogan M, Comoglu T, Gonul N (2008). Comparison of the quality and in vitro dissolution profiles of commercial losartan potassium film tablets. Turk J Pharm Sci, 5(2), 75-88.
- Mathur N, Kumar R, Tiwari K, Singh S, Fatima N (2015). Evaluation of quality control parameters on various brands of paracetamol tablet formulation. World J of Pharm and Pharma Sci 4(7): 976-984.
- Nagashree K (2015). Solid dosage forms: Tablets. J Pharm Analysis 4(2).
- Oscier CD, Milner QJW (2009). Peri‐operative use of paracetamol. Anaesthesia 64(1): 65-72.
- Sahle SB, Ayane AT, Wabe NT (2012). Comparative quality evaluation of paracetamol tablet marketed in Somali region of Ethiopia. J Pharm Sci Res 3(2): 545.
- Turk Farmakopesi (TF) (2017). TITCK 3(1): 1660-1662.
- United States Pharmacopeia (USP 32) (2009). In Rocville: United States Pharmacopeial Convention (pp. 1209-1210).
- Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N (2016). Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol 4(2): 1
Comparison of the pharmaceutical properties of paracetamol tablets belonging to different companies in the Northern Cyprus pharmaceutical market
Abstract
Paracetamol (PAR) tablets are commonly used over the counter formulations among the patients as analgesic and antipyretic. Therefore, the determination of the quality of these widely used tablets is important. On Northern Cyprus drug market, paracetamol formulations are provided various by pharmaceutical companies from different countries like Turkey, UK and local companies. In this study, three different brands (A, B, C) of traditional PAR (500 mg) tablets, selected for the evaluation of the pharmaceutical properties, were tested according to United States Pharmacopeia (USP) 32. Similarities and differences between conventional PAR tablets that are available in Northern Cyprus drug market were evaluated.
Keywords
Paracetamol tablet quality control dissolution profiles Northern Cyrprus Pharmaceutical Market
References
- Bhowmik D, Rajalakshmi S, Sampath Kumar KP (2014). Tablet manufacturing process and defects of tablets. Elixir Pharmacy 70: 24368-74.
- Comoglu T, Gonul N (2005). Quality control studies on conventional Carbamazepine tablets available on the Turkish drug market. Turk J Med Sci 35(4): 217-221.
- Gundogan M, Comoglu T, Gonul N (2008). Comparison of the quality and in vitro dissolution profiles of commercial losartan potassium film tablets. Turk J Pharm Sci, 5(2), 75-88.
- Mathur N, Kumar R, Tiwari K, Singh S, Fatima N (2015). Evaluation of quality control parameters on various brands of paracetamol tablet formulation. World J of Pharm and Pharma Sci 4(7): 976-984.
- Nagashree K (2015). Solid dosage forms: Tablets. J Pharm Analysis 4(2).
- Oscier CD, Milner QJW (2009). Peri‐operative use of paracetamol. Anaesthesia 64(1): 65-72.
- Sahle SB, Ayane AT, Wabe NT (2012). Comparative quality evaluation of paracetamol tablet marketed in Somali region of Ethiopia. J Pharm Sci Res 3(2): 545.
- Turk Farmakopesi (TF) (2017). TITCK 3(1): 1660-1662.
- United States Pharmacopeia (USP 32) (2009). In Rocville: United States Pharmacopeial Convention (pp. 1209-1210).
- Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N (2016). Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol 4(2): 1
Details
| Primary Language | English |
|---|---|
| Subjects | Pharmacology and Pharmaceutical Sciences |
| Journal Section | Research Article |
| Authors | |
| Publication Date | October 31, 2020 |
| Published in Issue | Year 2020 Volume: 3 Issue: 2 |
